阿立哌唑-话题@MedSci

#阿立哌唑#

7篇内容 | 1544人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2256301, encodeId=ac2d225630136, content=<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> <a href='/topic/show?id=6401801e374' target=_blank style='color:#2F92EE;'>#老年患者#</a> <a href='/topic/show?id=35136411609' target=_blank style='color:#2F92EE;'>#氯胺酮#</a> <a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a> <a href='/topic/show?id=caffe84982e' target=_blank style='color:#2F92EE;'>#经颅磁刺激#</a> <a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, objectTitle=BMJ Mental Health：老年患者难治性抑郁症的药物和非药物干预效果：系统综述和Meta分析, objectType=article, longId=866344, objectId=a23586634453, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/an-elderly-patient-at-the-hospital-PT6KR2Z.jpg, objectUrl=/article/show_article.do?id=a23586634453, replyNumber=0, likeNumber=31, createdTime=2025-03-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a23586634453, moduleTitle=BMJ Mental Health：老年患者难治性抑郁症的药物和非药物干预效果：系统综述和Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a23586634453)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2256304, encodeId=410722563044a, content=<a href='/topic/show?id=4f754322561' target=_blank style='color:#2F92EE;'>#多巴胺受体#</a> <a href='/topic/show?id=35136411609' target=_blank style='color:#2F92EE;'>#氯胺酮#</a> <a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a> <a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, objectTitle=Translational Psychiatry：通过阿立哌唑微调多巴胺受体信号以对抗氯胺酮的解离作用但不影响其抗抑郁效果, objectType=article, longId=866463, objectId=46558664630e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019552973_4754896.png, objectUrl=/article/show_article.do?id=46558664630e, replyNumber=0, likeNumber=29, createdTime=2025-03-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=46558664630e, moduleTitle=Translational Psychiatry：通过阿立哌唑微调多巴胺受体信号以对抗氯胺酮的解离作用但不影响其抗抑郁效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46558664630e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249182, encodeId=376c2249182ef, content=<a href='/topic/show?id=09f0e1554e6' target=_blank style='color:#2F92EE;'>#癫痫#</a> <a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a> <a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a> <a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a> <a href='/topic/show?id=423012358e85' target=_blank style='color:#2F92EE;'>#抗药性抑郁症#</a>, objectTitle=European Psychiatry：布普维坦与阿立哌唑在治疗抗药性抑郁症成人中的疗效和安全性比较：一项韩国全国性队列研究, objectType=article, longId=860552, objectId=f5f58605520e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230925/1695639372674_2570354.jpg, objectUrl=/article/show_article.do?id=f5f58605520e, replyNumber=0, likeNumber=26, createdTime=2025-01-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f5f58605520e, moduleTitle=European Psychiatry：布普维坦与阿立哌唑在治疗抗药性抑郁症成人中的疗效和安全性比较：一项韩国全国性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5f58605520e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1401131, encodeId=49ea140113145, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=氨磺必利、阿立哌唑和奥氮平疗效和副作用的性别差异, objectType=article, longId=737295, objectId=7829e37295d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7829e37295d4, replyNumber=0, likeNumber=88, createdTime=2022-08-31, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7829e37295d4, moduleTitle=氨磺必利、阿立哌唑和奥氮平疗效和副作用的性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7829e37295d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401130, encodeId=a2bf1401130cf, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=临床疗效差异：氨磺必利VS阿立哌唑VS奥氮平, objectType=article, longId=737051, objectId=89a2e370518e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89a2e370518e, replyNumber=0, likeNumber=110, createdTime=2022-08-28, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89a2e370518e, moduleTitle=临床疗效差异：氨磺必利VS阿立哌唑VS奥氮平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89a2e370518e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=Anesth Analg：内源性大麻素在阿立哌唑外周抗伤害作用中的研究, objectType=article, longId=180358, objectId=92601803585b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92601803585b, replyNumber=0, likeNumber=114, createdTime=2019-10-02, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92601803585b, moduleTitle=Anesth Analg：内源性大麻素在阿立哌唑外周抗伤害作用中的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92601803585b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401128, encodeId=1523140112871, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=J Psychopharmacol：更佳搭档：阿立哌唑让艾司西酞普兰更强大, objectType=article, longId=119631, objectId=f82811963150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f82811963150, replyNumber=0, likeNumber=0, createdTime=2017-11-12, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f82811963150, moduleTitle=J Psychopharmacol：更佳搭档：阿立哌唑让艾司西酞普兰更强大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f82811963150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401127, encodeId=72fd140112eef, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=Clin Neuropharm：阿立哌唑用于创伤后应激障碍, objectType=article, longId=118090, objectId=dc811180907b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc811180907b, replyNumber=0, likeNumber=115, createdTime=2017-10-31, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc811180907b, moduleTitle=Clin Neuropharm：阿立哌唑用于创伤后应激障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc811180907b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401126, encodeId=1a811401126f5, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=第4个适应症！大冢抗精神病药物Abilify(阿立哌唑)获日本批准治疗儿童自闭症谱系障碍, objectType=article, longId=79540, objectId=838be95405a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=838be95405a, replyNumber=0, likeNumber=100, createdTime=2016-10-10, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=838be95405a, moduleTitle=第4个适应症！大冢抗精神病药物Abilify(阿立哌唑)获日本批准治疗儿童自闭症谱系障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=838be95405a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401125, encodeId=beb5140112528, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, objectTitle=阿立哌唑致阴茎异常勃起一例, objectType=article, longId=22621, objectId=e835226210e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e835226210e, replyNumber=0, likeNumber=94, createdTime=2013-08-07, rootId=0, userName=huhuaidong388, userId=f7662296077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e835226210e, moduleTitle=阿立哌唑致阴茎异常勃起一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e835226210e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿立哌唑

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#Meta分析# #老年患者# #氯胺酮# #阿立哌唑# #经颅磁刺激# #难治性抑郁症#

BMJ Mental Health：老年患者难治性抑郁症的药物和非药物干预效果：系统综述和Meta分析

2025-03-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多巴胺受体# #氯胺酮# #阿立哌唑# #抗抑郁#

Translational Psychiatry：通过阿立哌唑微调多巴胺受体信号以对抗氯胺酮的解离作用但不影响其抗抑郁效果

2025-03-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#癫痫# #阿立哌唑# #运动障碍# #回顾性研究# #抗药性抑郁症#

European Psychiatry：布普维坦与阿立哌唑在治疗抗药性抑郁症成人中的疗效和安全性比较：一项韩国全国性队列研究

2025-01-22发表于陕西省

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

氨磺必利、阿立哌唑和奥氮平疗效和副作用的性别差异

2022-08-31

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

临床疗效差异：氨磺必利VS阿立哌唑VS奥氮平

2022-08-28

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

Anesth Analg：内源性大麻素在阿立哌唑外周抗伤害作用中的研究

2019-10-02

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

J Psychopharmacol：更佳搭档：阿立哌唑让艾司西酞普兰更强大

2017-11-12

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

Clin Neuropharm：阿立哌唑用于创伤后应激障碍

2017-10-31

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

第4个适应症！大冢抗精神病药物Abilify(阿立哌唑)获日本批准治疗儿童自闭症谱系障碍

2016-10-10

huhuaidong388 (审核中...)

前往app查看评论内容

#阿立哌唑#

阿立哌唑致阴茎异常勃起一例

2013-08-07

科室
- - 订阅+
  - 更多科室
工具
服务